ACT Capital Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

ACT Capital Management’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$177K	Hold	170,500	–	–	0.24%	40
2022 Q2	$280K	Hold	170,500	–	–	0.39%	36
2022 Q1	$501K	Hold	170,500	–	–	0.53%	33
2021 Q4	$815K	Hold	170,500	–	–	0.59%	34
2021 Q3	$1.29M	Hold	170,500	–	–	0.67%	32
2021 Q2	$1.27M	Buy	+170,500	New	+$1.31M	0.65%	34

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

ACT Capital Management's SURF Position: Q3 2022 in Review

ACT Capital Management held its Surface Oncology, Inc. Common Stock (SURF) position steady in Q3 2022 at 170,500 shares worth $177K. The position accounts for 0.24% of the portfolio, ranked #40.

ACT Capital Management first reported a position in SURF in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.29M in Q3 2021. 79 funds tracked by Wall St. Rank hold SURF as of Q3 2022.

ACT Capital Management held 170,500 shares of Surface Oncology, Inc. Common Stock worth $177K as of Q3 2022.
ACT Capital Management left its Surface Oncology, Inc. Common Stock share count unchanged in Q3 2022.
Surface Oncology, Inc. Common Stock made up 0.24% of ACT Capital Management's portfolio in Q3 2022, its #40 holding.
ACT Capital Management first reported a position in Surface Oncology, Inc. Common Stock in Q2 2021 and has held it in 6 quarters since.
ACT Capital Management's Surface Oncology, Inc. Common Stock position peaked at $1.29M in Q3 2021.
79 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2022.

Based on ACT Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.